ProPhase Labs Inc. has entered into a Stock Purchase Agreement with Generating Alpha Ltd., granting the company access to an equity line facility of up to $10 million. Under the agreement, ProPhase Labs can elect to sell shares of its common stock to the investor over time, at its own discretion. As part of the commitment fee for this arrangement, the company has issued 549,105 shares of common stock and a prefunded warrant to acquire up to 240,369 additional shares, with the warrant exercisable at no cost on a cashless basis. The securities were issued in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act and Regulation D.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-003456), on January 23, 2026, and is solely responsible for the information contained therein.